GlaxoSmithKline Consumer Healthcare has informed that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from June 15, 2019 and shall end 48 hours after public announcement of the Unaudited Financial Results for the Quarter ended June 30, 2019.
The above information is a part of company’s filings submitted to BSE.